CG
SCMP

Cutler Group’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Cutler Group’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,000
Closed -$1K – 7828
2016
Q2 		$1K Buy
+1,000
New +$11.2K ﹤0.01% 6456
2016
Q1 		– Sell
-3,300
Closed -$41K – 7650
2015
Q4 		$41K Buy
+3,300
New +$59.2K ﹤0.01% 2684

Other funds holding SCMP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RI
Redwood Investments Boston, Massachusetts $267M AUM 11.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cutler Group's SCMP Position: Q1 2016 in Review

Cutler Group sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2016, closing a stake of 1,500 shares — an estimated $25K sold.

Cutler Group first reported a position in SCMP in Q4 2015 and held it in 1 quarter. The position peaked at $25K in Q4 2015. 134 funds tracked by Wall St. Rank hold SCMP as of Q1 2016.

  • Cutler Group reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
  • Cutler Group sold 1,500 Sucampo Pharmaceuticals, Inc. shares in Q1 2016, an estimated $25K.
  • Cutler Group first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2015 and held it in 1 quarter.
  • Cutler Group's Sucampo Pharmaceuticals, Inc. position peaked at $25K in Q4 2015.
  • 134 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2016.

Based on Cutler Group's 13F filing for Q1 2016, filed 8 Jun 2016.